The company said the government’s support would be significant and could help limit tens of thousands of lawsuits.

Bayer is reshaping its pharmaceutical business with a new operating model designed to enhance collaboration and bring research & development and commercialization closer together. In a recent episode ...

Bayer has cleared out four cancer candidates from its early-stage pipeline, including a STAT3 inhibitor acquired as part of its buyout of Vividion Therapeutics. The Vividion asset in question, called ...

Green Bay School District Superintendent Vicki Bayer will retire at the end of the 2025-26 school year, the district announced Oct. 28. “It has been an honor to serve as Superintendent and to lead ...

When the NFL decided to add commercials to RedZone Channel — which had long been advertised as “Seven hours of commercial-free football” — the spin from the league was that these commercials would be ...

Bayer Aktiengesellschaft remains deeply undervalued despite ongoing business struggles and litigation headwinds, with significant upside potential if challenges are resolved. Bayer's Q2 '25 results ...

Bayer Leverkusen welcome Eredivisie side PSV Eindhoven to the BayArena for their second Champions League game of the season tonight with kick-off scheduled for 21:00 CET. Axel Tape and Ernest Poku get ...

Bayer AG’s menopause drug won the backing of European regulators, a step toward the rollout of a medicine that reduces hot flashes. The European Medicines Agency recommended approval for Lynkuet, a ...

Bayer announced July 30 that it has submitted applications in four major agricultural markets—the European Union, Brazil, Canada, and the United States—for a new herbicide with a new mode of action, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Bayer AG has reached agreements ...

Bayer’s Roundup pesticide is linked with cancer. Its multi-million dollar fight to evade justice and accountability threatens to leave sick people holding the bag. Bayer’s Roundup pesticide is linked ...

Bayer is a deep contrarian play, trading at less than 6x P/E, with potential for 100%+ upside if litigation risks subside. The main risks are ongoing glyphosate litigation and pharma pricing pressures ...